Skip to content
ClinCalc Pro
Menu
Opioid Analgesic

Fentanyl

Brand names: Sublimaze, PecFent (intranasal)

Fentanyl is a potent short-acting synthetic opioid used in children for procedural and intraoperative analgesia, sedation in intensive care and for severe pain, by intravenous, intranasal and transmucosal routes.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is a strong mu-opioid receptor agonist, producing rapid analgesia and sedation with a fast onset and short duration after a single dose.

Prescribing in practice

  • The dominant risk is dose-dependent respiratory depression, which can be profound and delayed, so it must be given with monitoring, resuscitation equipment and naloxone available and titrated carefully.
  • Rapid intravenous administration can cause chest-wall rigidity impairing ventilation, and effects are potentiated by other sedatives and CNS depressants.
  • Use weight-based dosing from a children's formulary and reserve transdermal formulations for opioid-tolerant children with stable chronic pain.

Monitoring

Continuously monitor respiratory rate, oxygen saturation, sedation level and blood pressure during and after administration.

Counselling the patient

  • Drowsiness and slowed breathing can occur, so the child must be observed closely.
  • Carers of children on patches should keep used and unused patches away from others and dispose of them safely.
  • Report any difficulty breathing, excessive sleepiness or unresponsiveness immediately.

Evidence & guidelines

Fentanyl is widely used for paediatric procedural and perioperative analgesia, with dosing and monitoring directed by specialist anaesthetic and intensive care practice.

Reference: RCEM Paediatric Pain Guidelines; Borland et al. (2007) intranasal fentanyl evidence; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.